Radiopharmaceuticals & Contrast Media Market - Share, Size & Industry Analysis

The report covers Radiopharmaceuticals Market Trends and it is Segmented by radiopharmaceuticals (by type of imaging modality (SPECT (Tc-99, Tl-201, Ga-67, I-123, and other SPECTs), PET (F-18, Rb-82, and other PETs), and application (diagnostic application (SPECT applications (cardiology, neurology, thyroid, and other SPECT applications) and PET application (oncology, cardiology, neurology, and other PET applications)), therapeutic application (thyroid, lymphoma, endocrine tumors, and other therapeutic applications), contrast media (type (iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media), procedure (X-ray/computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound), and applications (cardiovascular disease, oncology, gastrointestinal disorders, neurological disorders, and other indications), and geography(North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

本报告涵盖放射性药物市场趋势分析，并根据放射性药物（按成像方式分类，包括SPECT（Tc-99、Tl-201、Ga-67、I-123及其他SPECT）、PET（F-18、Rb-82及其他PET）以及应用领域（诊断应用（SPECT应用包括心脏病学、神经病学、甲状腺及其他SPECT应用；PET应用包括肿瘤学、心脏病学、神经病学及其他PET应用），治疗应用（甲状腺、淋巴瘤、内分泌肿瘤及其他治疗应用），对比介质（类型包括碘化对比介质、基于钆的对比介质、微泡对比介质及基于钡的对比介质），程序（X射线/计算机断层扫描（CT）、磁共振成像（MRI）及超声），应用领域包括心血管疾病、肿瘤学、胃肠道疾病、神经疾病及其他适应症），以及地理区域（北美、欧洲、亚太地区、中东及非洲、南美洲））进行细分。报告提供了上述各细分市场的价值（以百万美元为单位）。